Return On Equity of CNS Pharmaceuticals, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
CNS Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • CNS Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -130%, a 119% decline year-over-year.
  • CNS Pharmaceuticals, Inc. annual Return On Equity for 2024 was -7384%, a 122% decline from 2023.
  • CNS Pharmaceuticals, Inc. annual Return On Equity for 2023 was 33276%.
  • CNS Pharmaceuticals, Inc. annual Return On Equity for 2022 was -151%, a 1.6% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

CNS Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -130% -826% -119% 01 Jul 2025 30 Sep 2025
Q2 2025 -184% -613% -143% 01 Apr 2025 30 Jun 2025
Q1 2025 -385% -1243% -145% 01 Jan 2025 31 Mar 2025
Q4 2024 -7384% -40661% -122% 01 Oct 2024 31 Dec 2024
Q3 2024 696% +1299% 01 Jul 2024 30 Sep 2024
Q2 2024 429% +752% 01 Apr 2024 30 Jun 2024
Q1 2024 857% +1085% 01 Jan 2024 31 Mar 2024
Q4 2023 33276% +33428% 01 Oct 2023 31 Dec 2023
Q3 2023 -603% -464% -333% 01 Jul 2023 30 Sep 2023
Q2 2023 -324% -185% -134% 01 Apr 2023 30 Jun 2023
Q1 2023 -228% -93% -69% 01 Jan 2023 31 Mar 2023
Q4 2022 -151% -2% -1.6% 01 Oct 2022 31 Dec 2022
Q3 2022 -139% -17% -14% 01 Jul 2022 30 Sep 2022
Q2 2022 -138% -14% -11% 01 Apr 2022 30 Jun 2022
Q1 2022 -135% +7% +4.7% 01 Jan 2022 31 Mar 2022
Q4 2021 -149% -4% -2.5% 01 Oct 2021 31 Dec 2021
Q3 2021 -122% +61% +33% 01 Jul 2021 30 Sep 2021
Q2 2021 -124% +54% +30% 01 Apr 2021 30 Jun 2021
Q1 2021 -141% +21% +13% 01 Jan 2021 31 Mar 2021
Q4 2020 -145% +68% +32% 01 Oct 2020 31 Dec 2020
Q3 2020 -183% -3777% -105% 01 Jul 2020 30 Sep 2020
Q2 2020 -179% -2596% -107% 01 Apr 2020 30 Jun 2020
Q1 2020 -163% -1774% -110% 01 Jan 2020 31 Mar 2020
Q4 2019 -214% -3005% -108% 01 Oct 2019 31 Dec 2019
Q3 2019 3595% 01 Jul 2019 30 Sep 2019
Q2 2019 2418% 01 Apr 2019 30 Jun 2019
Q1 2019 1611% 01 Jan 2019 31 Mar 2019
Q4 2018 2791% 01 Oct 2018 31 Dec 2018

CNS Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -7384% -40661% -122% 01 Jan 2024 31 Dec 2024
2023 33276% +33428% 01 Jan 2023 31 Dec 2023
2022 -151% -2% -1.6% 01 Jan 2022 31 Dec 2022
2021 -149% -4% -2.5% 01 Jan 2021 31 Dec 2021
2020 -145% +68% +32% 01 Jan 2020 31 Dec 2020
2019 -214% -3005% -108% 01 Jan 2019 31 Dec 2019
2018 2791% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.